Genes discovered that hold the key for Alzheimers Disease

Alzheimers Disease Treatment Potential.  Discovery of five genes that may hold the key to an effective treatment of Alzheimer's Disease.   New treatments possible for Alzheimer's Disease patients.

 Onlymyhealth Staff Writer
Written by: Onlymyhealth Staff WriterUpdated at: Apr 05, 2011 14:18 IST
Genes discovered that hold the key for Alzheimers Disease

Malaria & Dengue Day 2023: Fever Causes, Symptoms and Prevention Guide - Onlymyhealth

Highlights of the New Research Findings on Alzheimer's

Five new genes have been discovered that are now known to be linked to Alzheimer's.    These five new genes are claimed to raise the risk of the disease of having Alzheimer's.  This identification of these five new genes may pave the way to radically new treatments for the disease in 10 - 15 years.  At present a total of ten genes have been identified that are linked to Alzheimer's disease.  This discovery brings us a step closer to finding a treatment for dementia.



Five genes that hold key to Alzheimer's 'identified'


London, Apr 4 (PTI) In a breakthrough which may pave the way for an effective treatment for Alzheimer's, scientists have identified five genes which they claim raise the risk of the disease.  With the discovery of the five new genes, a total of 10 genes are now known to be linked with the most common form of dementia, says the international team of scientists from the US and Britain.


Lead scientist Professor Julie Williams of Cardiff University said that with the breakthrough, it may soon be possible to identify patients most at risk from Alzheimer's disease, and offer them drugs to prevent it.


"I can envisage in 10 to 15 years' time we may be taking a number of drugs to prevent the onset of Alzheimer's in the same way as we take statins now to prevent heartdisease," the 'Daily Express' quoted her as saying.  The research involved analysing the DNA of nearly 60,000 people with and without the disease.


Prof Williams said that eventually a simple blood test could be used to identify signs of the disease.  She said: "What is exciting about our findings is that the genetic variations we've found all fit together. Modern technology has allowed us to complete this work and we're really getting to the crux of what causes Alzheimer's."


Experts have hailed the findings published in the latest edition of the 'Nature Genetics' journal.  Dr Susanne Sorensen, of the Alzheimer's Society, said: "These studies will give scientists clues as to how the disease might develop. Most importantly their identification could also lead to the development of drug treatments in the longer term."


Rebecca Wood of Alzheimer's Research UK, which part-funded the study, added: 'These findings are a step towards defeating dementia.